ArticleHepatology, medicine and policy2018

Design of the Prospective Real-world Outcomes Study of hepatic encephalopathy Patients' Experience on Rifaximin-α (PROSPER): an observational study among 550 patients.

Aleksander Krag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.